20 sodium pentobarbital treated with chlorpromazine. The corticotrophic effect of vasopressin in these rats is not potentiated so that the increase in blood pressure per se is not obligatory for the pituitary ACTH release.
Removal of the posterior and intermediate lobes of the pituitary in the rat leads to a reduction in ACTH release in response to neurogenic stress and to abnormal behaviour in a conditioned emotional situation. These abnormalities are counteracted by the treatment of posterior lobectomized rats with long-acting Pitressin or purified lysine vasopressin. These results suggest an effect of vasopressin on higher brain centres and via these centres on ACTH release. Accordingly, vasopressin exerts its stimulatory effect on ACTH release at multiple sites in the body.
Dr W R Greig, Dr J A Boyle, Dr M K Jasani and Dr J D Maxwell (University Departments ofMedicine and Steroid Biochemistry, Royal Infirmary, Glasgow, and the Centrefor Rheumatic Diseases, Glasgow)
Corticotrophin Stimulation Tests
The concentrations of plasma cortisol, measured by the rapid fluorimetric method of Mattingly (1962, J. clin. Path. 15, 374) have been estimated before (basal) and thirty minutes after the intramuscular injection of 250 pg of the synthetic polypeptide Pl-24-corticotrophin (Synacthen) in a total of 242 patients. The results indicate that this procedure, the Synacthen test (Wood et al., 1965, Lancet i, 243; Greig et al., 1966, J. Endocr. 34, 411) , can be a safe and reliable test of adrenocortical function. If subjects without endocrine disorder are tested in the morning, the basal cortisol should not be less than 6 pg/100 ml, the increment should not be less than 7 pg/100 ml and the cortisol thirty minutes after Synacthen should not be less than 18 ,g/100 ml.
From studies on subjects with adrenocortical atrophy either secondary to corticosteroid therapy or to primary failure of the pituitary or adrenal, these criteria for adrenocortical insufficiency were validated. The Synacthen test results in this group of subjects always correlated with those obtained using a four-hour corticotrophin infusion test (Christy et al., 1956 , J. clin. Endocr. 16, 1059 and with the final diagnosis made by other criteria.
Higher than normal results with the Synacthen test consisted of a basal plasma cortisol above 26 pg/100 ml, an increment greater than 25 pg/100 ml and a plasma cortisol thirty minutes after Synacthen, greater than 47 ,ug/100 ml. High results were characteristic of general medical but non-endocrine illness and of gross simple obesity. High results were also found in patients with surgically proven adrenal hyperplasia (producing Cushing's syndrome).
Duplicate Synacthen tests were reproducible, and they may be employed not only in outpatients but in the elderly and infirm, in children and during pregnancy, but more information is required about the latter two groups. 
Some Aspects ofthe Pharmacology ofMetyrapone
Metyrapone is used in the assessment of pituitaryadrenal function, a normal response being dependent on the degree and duration of 11 ,B-hydroxylase inhibition and upon the half-life of cortisol. Complete inhibition, however, of I I -hydroxylase is not obtained with the usual dose regime of 750 mg metyrapone four-hourly by mouth, cortisol secretion rates being nearly normal.
Plasma metyrapone and 1 1-hydroxycorticoid (1 1-OHCS) levels were measured at intervals of thirty minutes, one hour, two hours and four hours after the oral administration of 750 mg metyrapone in 11 subjects. The absorption of the metyrapone was variable, but most subjects showed peak plasma levels at one hour (mean value 370 ,ug/100 ml). Four hours after administration of the metyrapone the plasma levels had fallen (mean value 50 ,ug/100 ml), while plasma 11-OHCS values had risen, after being temporarily depressed.
The half-life of metyrapone was estimated at 20-26 minutes in 3 subjects following the slow intravenous injection of 600 mg metyrapone ditartrate.
In one subject, after ingesting 3 2 g metyrapone in a slow-release base, plasma levels were maintained between 550 and 610 pg/100 ml for four hours but at six hours, had fallen to 35 .g/100 ml.
A study has been done in one subject to determine the relationship between plasma metyrapone levels and percentage suppression of plasma 1 1-OHCS during a period of maximal adrenocortical stimulation with Synacthen. The first day Synacthen was given by intravenous infusion at a
